Search Header Logo
U.S. Drugmaker Merck Enters Vaccine Race With 2 New Partnerships

U.S. Drugmaker Merck Enters Vaccine Race With 2 New Partnerships

Assessment

Interactive Video

Health Sciences, Biology

University

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

Merck is joining the race to develop a COVID-19 vaccine, collaborating with nonprofit organizations to create two vaccines. The company aims to leverage its Ebola vaccine technology for one of the COVID-19 vaccines. The US government, led by Health and Human Services Secretary Alex Azar, aims to produce 300 million vaccine doses by 2021. Experts are focusing on which vaccine projects to fund significantly.

Read more

5 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What is Merck's plan regarding the development of a second vaccine?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the purpose of the partnership mentioned in the text?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What technology will the second COVID-19 vaccine utilize?

Evaluate responses using AI:

OFF

4.

OPEN ENDED QUESTION

3 mins • 1 pt

Who is the Health and Human Services Secretary mentioned in the text?

Evaluate responses using AI:

OFF

5.

OPEN ENDED QUESTION

3 mins • 1 pt

What goal has the US government set for COVID-19 vaccine doses?

Evaluate responses using AI:

OFF

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?